Prediction for recurrence following antithyroid drug therapy for Graves’ hyperthyroidism
Archives of Endocrinology and Metabolism · 12.05.2023 · 67 (4)
DOI: 10.20945/2359-3997000000609 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Endocrinology and Metabolism, erschienen am 12.05.2023. Verfasst von Huan Weng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Shantou Central Hospital, Shantou, China. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Hyperthyroidism, Graves Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Shantou Central Hospital, Shantou, China.
- School of Public Health, Sun Yat-sen University, Guangzhou, China.
- School of Public Health, Sun Yat-sen University, Guangzhou, China, xulin27@mail.sysu.edu.cn.
Zitieren
APA
Weng, H., Tian, W. B., Xiao, Z. D., & Xu, L. (2023). Prediction for recurrence following antithyroid drug therapy for Graves’ hyperthyroidism. Archives of Endocrinology and Metabolism, 67(4). https://doi.org/10.20945/2359-3997000000609
Vancouver
Weng H, Tian WB, Xiao ZD, Xu L. Prediction for recurrence following antithyroid drug therapy for Graves’ hyperthyroidism. Archives of Endocrinology and Metabolism. 2023;67(4). doi:10.20945/2359-3997000000609
BibTeX
@article{Weng2023,
author = {Weng, Huan and Tian, Wen Bo and Xiao, Zi Dong and Xu, Lin},
title = {Prediction for recurrence following antithyroid drug therapy for Graves’ hyperthyroidism},
journal = {Archives of Endocrinology and Metabolism},
year = {2023},
volume = {67},
number = {4},
doi = {10.20945/2359-3997000000609}
}
EUVIMED